Ligand validation:2EVU

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2EVU_GOL_A_502	30%	89%	0.235	0.902	0.2	0.44	-	-	0	0	100%	1
2EVU_GOL_A_504	27%	91%	0.165	0.813	0.14	0.43	-	-	1	0	100%	1
2EVU_GOL_A_501	20%	90%	0.276	0.881	0.21	0.4	-	-	3	0	100%	1
2EVU_GOL_A_503	18%	90%	0.264	0.849	0.11	0.5	-	-	2	0	100%	1
2EVU_GOL_A_500	2%	90%	0.451	0.694	0.22	0.39	-	-	0	0	100%	1
2EVU_GOL_A_505	1%	90%	0.336	0.51	0.14	0.46	-	-	0	0	100%	1
2F2B_GOL_A_501	21%	0%	0.188	0.796	4.56	5.84	5	3	0	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.